ConductScience.org, home

Paper36928207

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.

Grignano E and 12 others. Cell Death Discov, 2023. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Papers, record 36928207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928207

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.
PubMed
Journal
Cell Death Discov
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
5.73
iCite
Revised in PubMed
2023-03-20
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grignano EEhttps://orcid.org/0000-0003-2512-1039
2Cantero-Aguilar LL
3Tuerdi ZZ
4Chabane TT
5Vazquez RR
6Johnson NN
7Zerbit JJ
8Decroocq JJ
9Birsen RR
10Fontenay MM
11Kosmider OOhttps://orcid.org/0000-0002-6021-4057
12Chapuis NN
13Bouscary DD

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132431605Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma.Front Pharmacol2020https://conductscience.org/library/papers/32431605PubMed
226186940Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.Blood2015https://conductscience.org/library/papers/26186940PubMed
324439385Regulation of ferroptotic cancer cell death by GPX4.Cell2014https://conductscience.org/library/papers/24439385PubMed
421991581Ferritin and metallothionein: dangerous liaisons.Chem Commun (Camb)2011https://conductscience.org/library/papers/21991581PubMed
523502468The role of metallothionein in oxidative stress.Int J Mol Sci2013https://conductscience.org/library/papers/23502468PubMed
624844246Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis.Elife2014https://conductscience.org/library/papers/24844246PubMed
719177017Single-vector inducible lentiviral RNAi system for oncology target validation.Cell Cycle2009https://conductscience.org/library/papers/19177017PubMed
827141961Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.Nucleic Acids Res2016https://conductscience.org/library/papers/27141961PubMed
927477901Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.Cancer Lett2016https://conductscience.org/library/papers/27477901PubMed
1034262021DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.Cell Death Dis2021https://conductscience.org/library/papers/34262021PubMed
1131740834The chemical basis of ferroptosis.Nat Chem Biol2019https://conductscience.org/library/papers/31740834PubMed
1223586463Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.BMC Bioinformatics2013https://conductscience.org/library/papers/23586463PubMed
1325516281Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol2014https://conductscience.org/library/papers/25516281PubMed
1426407947Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.Phytomedicine2015https://conductscience.org/library/papers/26407947PubMed
1521907397Artemisinin: discovery from the Chinese herbal garden.Cell2011https://conductscience.org/library/papers/21907397PubMed
1612869643Molecular modes of action of artesunate in tumor cell lines.Mol Pharmacol2003https://conductscience.org/library/papers/12869643PubMed
1733363031Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.Front Oncol2020https://conductscience.org/library/papers/33363031PubMed
1811764006Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.Life Sci2001https://conductscience.org/library/papers/11764006PubMed
1931114026Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.Cell Death Differ2020https://conductscience.org/library/papers/31114026PubMed
2027015352Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.Hepatology2016https://conductscience.org/library/papers/27015352PubMed

See all 37 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42776828Metallothionein Isoforms in Acute Myeloid Leukemia: Roles in Survival, Differentiation, and Stress Adaptation.Hematol Rep2026https://conductscience.org/library/papers/42776828PubMed
42694667DHA Targets RAB1B to Mediate the Driving Force Transmission of Copper Ion Vesicular Endocytosis Under Copper Overload for Promoting Cuproptosis and Ferroptosis in Hepatic Stellate Cells.Int J Biol Sci2026https://conductscience.org/library/papers/42694667PubMed
42524207Arteannuin B Induces Ferroptosis in Colorectal Cancer Cells via GDF15/HMGCS1/GPX4 Axis.J Cancer2026https://conductscience.org/library/papers/42524207PubMed
42431858Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in WI-38 replicative senescent cells.Cell Death Dis2026https://conductscience.org/library/papers/42431858PubMed
42196362Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked Ca2+ Dysregulation and ATF3/SLC7A11 Regulation.Int J Mol Sci2026https://conductscience.org/library/papers/42196362PubMed
42053642Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42053642PubMed
41935320Therapeutic profiling of dihydroartemisinin using in vitro and in vivo models reveals anti-glioma potential.Cancer Cell Int2026https://conductscience.org/library/papers/41935320PubMed
41833023The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A Systematic Review of In Vitro, In Vivo, and In Silico Studies.Anticancer Agents Med Chem2026https://conductscience.org/library/papers/41833023PubMed
41741409The protective up-regulation of metallothionein-2A in intervertebral disc degeneration inhibits nucleus pulposus cell ferroptosis through activation of the PI3K/AKT/mTOR pathway.Cell Death Discov2026https://conductscience.org/library/papers/41741409PubMed
41640441NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fate.Front Oncol2025https://conductscience.org/library/papers/41640441PubMed
41531728HMOX1 drives dihydroartemisinin-sensitized ferroptosis antagonized by mitochondrial fusion.iScience2026https://conductscience.org/library/papers/41531728PubMed
41518462Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications.Apoptosis2026https://conductscience.org/library/papers/41518462PubMed
41462004Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential.Cell Oncol (Dordr)2025https://conductscience.org/library/papers/41462004PubMed
41356368Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in senescent cells.Res Sq2025https://conductscience.org/library/papers/41356368PubMed
41117998Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs.Discov Oncol2025https://conductscience.org/library/papers/41117998PubMed
40892295Synergistic Ferroptosis-Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization.Nanomicro Lett2025https://conductscience.org/library/papers/40892295PubMed
40822033Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40822033PubMed
40490812Natural anti-cancer products: insights from herbal medicine.Chin Med2025https://conductscience.org/library/papers/40490812PubMed
40488837Ferroptosis: a novel therapeutic warrior in the battle against leukemia.Apoptosis2025https://conductscience.org/library/papers/40488837PubMed
40241743BMAL1-depletion remodels ceramide metabolism to regulate ferroptosis and sorafenib chemosensitivity in acute myeloid leukemia.iScience2025https://conductscience.org/library/papers/40241743PubMed

See all 38 cited byDownload CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CP1356PubTator's text mininghttps://conductscience.org/library/genes/1356NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
F32152PubTator's text mininghttps://conductscience.org/library/genes/2152NCBI Gene
FANCC2176PubTator's text mininghttps://conductscience.org/library/genes/2176NCBI Gene
FTH12495PubTator's text mininghttps://conductscience.org/library/genes/2495NCBI Gene
FTL2512PubTator's text mininghttps://conductscience.org/library/genes/2512NCBI Gene
GCLC2729PubTator's text mininghttps://conductscience.org/library/genes/2729NCBI Gene
GCLM2730PubTator's text mininghttps://conductscience.org/library/genes/2730NCBI Gene
GPX42879PubTator's text mininghttps://conductscience.org/library/genes/2879NCBI Gene
HMOX13162PubTator's text mininghttps://conductscience.org/library/genes/3162NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IREB23658PubTator's text mininghttps://conductscience.org/library/genes/3658NCBI Gene
LAMP23920PubTator's text mininghttps://conductscience.org/library/genes/3920NCBI Gene
MAP1LC3A84557PubTator's text mininghttps://conductscience.org/library/genes/84557NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
MT1E4493PubTator's text mininghttps://conductscience.org/library/genes/4493NCBI Gene
MT1F4494PubTator's text mininghttps://conductscience.org/library/genes/4494NCBI Gene
MT1G4495PubTator's text mininghttps://conductscience.org/library/genes/4495NCBI Gene
MT1M4499PubTator's text mininghttps://conductscience.org/library/genes/4499NCBI Gene
MT1X4501PubTator's text mininghttps://conductscience.org/library/genes/4501NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36928207

GET https://conductscience.org/api/papers/v1/36928207/references?page=2